677 related articles for article (PubMed ID: 30851700)
1. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
2. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
Zou R; Gui X; Zhang J; Tian Y; Liu X; Tian M; Chen T; Wu H; Chen J; Dai J; Cai H
Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
4. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
Ohshimo S; Ishikawa N; Horimasu Y; Hattori N; Hirohashi N; Tanigawa K; Kohno N; Bonella F; Guzman J; Costabel U
Respir Med; 2014 Jul; 108(7):1031-9. PubMed ID: 24835074
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.
Tachibana K; Inoue Y; Nishiyama A; Sugimoto C; Matsumuro A; Hirose M; Kitaichi M; Akira M; Arai T; Hayashi S; Inoue Y
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):113-22. PubMed ID: 22117502
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
[TBL] [Abstract][Full Text] [Related]
7. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
Papiris SA; Tomos IP; Karakatsani A; Spathis A; Korbila I; Analitis A; Kolilekas L; Kagouridis K; Loukides S; Karakitsos P; Manali ED
Cytokine; 2018 Feb; 102():168-172. PubMed ID: 28847533
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.
Schupp JC; Binder H; Jäger B; Cillis G; Zissel G; Müller-Quernheim J; Prasse A
PLoS One; 2015; 10(1):e0116775. PubMed ID: 25590613
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis.
Jude C; Dejica D; Samasca G; Balacescu L; Balacescu O
Rheumatol Int; 2013 Apr; 33(4):1031-7. PubMed ID: 23011084
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Gui X; Qiu X; Xie M; Tian Y; Min C; Huang M; Hongyan W; Chen T; Zhang X; Chen J; Cao M; Cai H
Biomed Res Int; 2020; 2020():3424208. PubMed ID: 32104688
[TBL] [Abstract][Full Text] [Related]
12. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
13. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
14. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
15. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis.
Antoniou KM; Tzouvelekis A; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Rachiotis G; Tzanakis N; Bouros D; Milic-Emili J; Siafakas NM
Chest; 2006 Oct; 130(4):982-8. PubMed ID: 17035428
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation.
Arai T; Hirose M; Kagawa T; Hatsuda K; Inoue Y
J Thorac Dis; 2023 Feb; 15(2):300-310. PubMed ID: 36910057
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
19. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
[TBL] [Abstract][Full Text] [Related]
20. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
